Clinical Trial Update: BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BMS-247550 in patients with recurrent or metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BMS-247550

Snippet

Sponsor: University of Chicago | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED